| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.69B | 17.96B | 16.50B | 13.36B | 14.04B | 14.29B |
| Gross Profit | 17.69B | 17.96B | 16.50B | 13.36B | 14.04B | 14.29B |
| EBITDA | 8.52B | 8.27B | 9.62B | 6.88B | 6.61B | 6.39B |
| Net Income | 5.76B | 5.25B | 6.52B | 4.52B | 4.07B | 3.47B |
Balance Sheet | ||||||
| Total Assets | 48.38B | 49.94B | 46.11B | 39.38B | 37.14B | 37.99B |
| Cash, Cash Equivalents and Short-Term Investments | 17.88B | 21.39B | 22.07B | 22.03B | 19.20B | 19.93B |
| Total Debt | 10.56B | 9.00B | 9.00B | 9.34B | 9.00B | 9.00B |
| Total Liabilities | 15.56B | 16.43B | 14.69B | 13.34B | 12.82B | 14.71B |
| Stockholders Equity | 32.82B | 33.51B | 31.44B | 26.05B | 24.32B | 23.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.39B | 4.37B | 2.80B | 2.65B | 5.87B |
| Operating Cash Flow | 0.00 | 5.06B | 5.99B | 3.10B | 2.66B | 6.12B |
| Investing Cash Flow | 0.00 | -2.12B | -3.13B | 2.00B | -1.18B | -2.90B |
| Financing Cash Flow | 0.00 | -3.39B | -3.29B | -2.41B | -2.48B | -1.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥61.77B | 10.05 | 17.21% | 4.27% | 7.60% | 7.20% | |
76 Outperform | ¥47.63B | 7.03 | 6.18% | 4.42% | 1.56% | -9.90% | |
72 Outperform | ¥1.98T | 3.01 | 20.02% | 2.63% | 23.96% | 179.16% | |
72 Outperform | ¥184.53B | 7.61 | 7.40% | 5.60% | 3.10% | 17.73% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥119.83B | 8.60 | 5.11% | 5.07% | -19.64% | -31.08% | |
44 Neutral | ¥20.43B | 169.87 | ― | 1.85% | -40.77% | -91.81% |